GO:0010734 negative regulation of protein glutathionylation: Redox Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010734 describes any process that decreases the rate, frequency, or extent of protein glutathionylation, a reversible post-translational modification in which glutathione is attached to a protein cysteine via a disulfide bond.
• Protein glutathionylation acts as a global inhibitor of cell metabolism, desensitizing hydrogen peroxide signals and protecting cysteine residues from irreversible oxidation.
• Negative regulation of glutathionylation is essential for restoring enzyme activity after oxidative stress and for fine-tuning redox-sensitive signaling pathways.
• Key proteins whose glutathionylation state is regulated include uncoupling protein 2 (UCP2), protein tyrosine phosphatase 1B (PTP1B), glutathione transferase omega 1 (GSTO1), and the Gbb ligand.
• Dysregulated glutathionylation control is linked to metabolic disorders, cancer, and synaptic dysfunction, making it a target for therapeutic intervention.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable precise dissection of the enzymes and pathways that negatively regulate protein glutathionylation.
Description
Protein glutathionylation is a reversible post-translational modification in which a glutathione molecule is covalently attached to a protein cysteine residue through a disulfide linkage. This modification can alter protein function, localization, and stability, and it is increasingly recognized as a key mechanism for transducing redox signals. The Gene Ontology term GO:0010734, negative regulation of protein glutathionylation, encompasses any process that decreases the rate, frequency, or extent of this modification. Understanding how glutathionylation is negatively regulated is critical because excessive or persistent glutathionylation can desensitize hydrogen peroxide signals and globally inhibit cell metabolism. Conversely, failure to remove glutathione adducts can lead to sustained enzyme inactivation and cellular dysfunction. Researchers study negative regulation of protein glutathionylation to uncover how cells restore redox homeostasis after oxidative stress and to identify therapeutic targets in diseases such as cancer, diabetes, and neurodegeneration. The process is mediated by enzymes such as glutaredoxins and sulfiredoxins, which catalyze deglutathionylation, and by metabolic signals that modulate the availability of glutathione or the activity of glutathionylating enzymes. This article integrates authoritative QuickGO data with real PubMed literature to provide a research-grade overview of GO:0010734, its mechanisms, key genes, disease relevance, and experimental models.
negative regulation of protein glutathionylation At A Glance
| GO ID | GO:0010734 |
|---|---|
| GO term | negative regulation of protein glutathionylation |
| Ontology | biological_process |
| Synonym | negative regulation of protein amino acid glutathionylation |
| Major function | Decreases the rate, frequency, or extent of protein glutathionylation, a reversible post-translational modification |
| Related modification | Protein glutathionylation (addition of glutathione to protein cysteine via disulfide linkage) |
| Key enzymes | Glutaredoxins, sulfiredoxins, glutathione transferases |
| Biological context | Redox signaling, oxidative stress response, metabolic regulation |
| Disease relevance | Metabolic disorders, cancer, neurodegeneration |
What Is GO:0010734?
GO:0010734 (negative regulation of protein glutathionylation) is a biological process defined as any process that decreases the rate, frequency, or extent of protein glutathionylation. Protein glutathionylation itself is the protein modification process in which a glutathione molecule is added to a protein amino acid through a disulfide linkage. Thus, negative regulation of this process includes enzymatic deglutathionylation, inhibition of glutathionylating enzymes, or changes in glutathione availability that reduce the formation of protein-glutathione mixed disulfides.
Why Is negative regulation of protein glutathionylation Important in Cell Biology?
Negative regulation of protein glutathionylation is essential for maintaining cellular redox homeostasis and for preventing the persistent inactivation of metabolic enzymes and signaling proteins. Because glutathionylation can act as a global inhibitor of cell metabolism, its timely reversal is required to restore enzyme activity and to allow cells to respond dynamically to changes in hydrogen peroxide levels. Dysregulation of this process has been implicated in metabolic disorders such as impaired glucose-stimulated insulin secretion, in cancer through altered NF-kappaB signaling, and in synaptic dysfunction through abnormal degradation of the Gbb ligand. Therefore, understanding the mechanisms that negatively regulate glutathionylation provides insight into fundamental redox biology and offers potential therapeutic targets for a range of human diseases.
• Maintains redox homeostasis by reversing oxidative modifications on cysteine residues.
• Prevents irreversible oxidation of protein cysteines by temporarily shielding them with glutathione.
• Restores activity of metabolic enzymes after oxidative stress.
• Regulates insulin secretion through control of UCP2 glutathionylation state.
• Modulates inflammatory signaling by affecting NF-kappaB expression.
• Controls protein stability, as shown for Gbb degradation in synapse growth.
• Impacts macrophage function via glutathione transferase omega 1.
• Influences dietary selenium effects on PTP1B and triglyceride metabolism.
• Provides a mechanism for desensitizing hydrogen peroxide signals.
• Offers targets for therapeutic intervention in cancer and metabolic diseases.
What Happens During negative regulation of protein glutathionylation?
Recognition and removal of glutathione adducts
In simple terms: Enzymes find proteins that have glutathione stuck to them and remove it.
The primary mechanism for negative regulation of protein glutathionylation is the enzymatic removal of glutathione from protein cysteines, a process called deglutathionylation. Glutaredoxins are thiol-disulfide oxidoreductases that catalyze the reduction of protein-glutathione mixed disulfides using reducing equivalents from glutathione or NADPH. This reaction restores the free thiol group on the target protein, thereby reversing the functional consequences of glutathionylation.
Inhibition of glutathionylating enzymes
In simple terms: Stopping the enzymes that add glutathione to proteins.
Negative regulation can also occur by decreasing the activity or availability of enzymes that promote glutathionylation, such as glutathione transferases. For example, glutathione transferase omega 1 (GSTO1) can catalyze protein glutathionylation, and its regulation impacts macrophage function. By inhibiting these enzymes, cells reduce the rate at which glutathione is added to target proteins.
Modulation of glutathione availability
In simple terms: Changing how much glutathione is available to attach to proteins.
Because glutathione is the substrate for glutathionylation, processes that lower intracellular glutathione levels or alter the glutathione/glutathione disulfide ratio can negatively regulate protein glutathionylation. For instance, oxidative stress can initially increase glutathionylation, but subsequent adaptive responses that restore glutathione homeostasis can reduce it. Dietary selenium manipulation affects glutathione metabolism and thereby influences PTP1B glutathionylation.
Regulation by redox-sensitive signaling pathways
In simple terms: Cellular signals that tell the cell to remove glutathione from proteins.
Signaling pathways that sense hydrogen peroxide and other reactive oxygen species can activate deglutathionylation enzymes or suppress glutathionylating enzymes. This feedback regulation desensitizes hydrogen peroxide signals and prevents sustained metabolic inhibition. For example, the glutathionylation state of uncoupling protein 2 (UCP2) is dynamically regulated in response to glucose, affecting insulin secretion.
Proteasome-mediated degradation of glutathionylated proteins
In simple terms: Sometimes glutathionylation marks proteins for destruction, and negative regulation can prevent this.
In some cases, glutathionylation promotes proteasome-mediated degradation of target proteins, as shown for the Gbb ligand. Negative regulation of glutathionylation can therefore stabilize such proteins by preventing their degradation. This adds another layer of control over protein abundance and function.
Key Genes Involved in GO:0010734 negative regulation of protein glutathionylation
The following genes and proteins are experimentally implicated in the regulation of protein glutathionylation or in the consequences of its negative regulation, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| UCP2 | Mitochondrial uncoupling protein; its glutathionylation state controls glucose-stimulated insulin secretion | Metabolic regulation and diabetes research |
| PTP1B | Protein tyrosine phosphatase 1B; glutathionylation regulates its activity and lipid metabolism | Dietary selenium effects on triglyceride concentration |
| GSTO1 | Glutathione transferase omega 1; catalyzes protein glutathionylation in macrophages | Inflammatory and macrophage biology |
| Gbb | Glutathionylation promotes its proteasome-mediated degradation, inhibiting synapse growth | Neurodevelopment and synaptic plasticity |
| NF-kappaB | Transcription factor whose expression is linked to redox regulation in lung cancer | Cancer biology and inflammation |
| Glutaredoxin (Grx) | Enzyme that catalyzes deglutathionylation | Redox homeostasis and oxidative stress response |
| Sulfiredoxin | Enzyme involved in reducing oxidized cysteine residues, indirectly affecting glutathionylation | Redox signaling |
| Glutathione (GSH) | Substrate for glutathionylation; its availability affects modification levels | Cellular redox buffering |
| Thioredoxin (Trx) | Redox protein that can influence glutathionylation indirectly | Oxidative stress response |
| Nrf2 | Transcription factor regulating antioxidant response genes, including glutathione synthesis | Cellular defense against oxidative stress |
| GCL | Glutamate-cysteine ligase; rate-limiting enzyme in glutathione synthesis | Glutathione homeostasis |
| GSR | Glutathione reductase; regenerates reduced glutathione | Redox balance |
| GPx | Glutathione peroxidase; reduces hydrogen peroxide using glutathione | Hydrogen peroxide signaling |
| GST | Glutathione S-transferase family; some members catalyze glutathionylation | Detoxification and redox regulation |
| Keap1 | Redox sensor that regulates Nrf2 stability | Antioxidant response |
| SOD2 | Mitochondrial superoxide dismutase; affects mitochondrial redox state | Mitochondrial redox regulation |
| Catalase | Enzyme that decomposes hydrogen peroxide, influencing glutathionylation signals | Hydrogen peroxide metabolism |
How Is negative regulation of protein glutathionylation Regulated?
The negative regulation of protein glutathionylation is itself regulated at multiple levels. Enzymatic deglutathionylation by glutaredoxins is dependent on the availability of reduced glutathione and NADPH, linking the process to cellular metabolic status. Redox-sensitive signaling pathways, including those involving hydrogen peroxide, can activate or inhibit the enzymes that control glutathionylation. Additionally, dietary factors such as selenium can modulate the expression and activity of glutathione-related enzymes, thereby affecting the glutathionylation state of proteins like PTP1B. In macrophages, GSTO1 activity is regulated in response to inflammatory signals, influencing protein glutathionylation. The glutathionylation of UCP2 is dynamically regulated by glucose levels, which impacts insulin secretion. These regulatory inputs ensure that protein glutathionylation is rapidly and reversibly controlled in response to cellular needs.
negative regulation of protein glutathionylation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| UCP2 | Type 2 diabetes, impaired insulin secretion | Pancreatic beta-cell knockout or knock-in of UCP2 glutathionylation site |
| PTP1B | Obesity, dyslipidemia, insulin resistance | Liver-specific PTP1B knockout or point mutant mice |
| GSTO1 | Inflammatory diseases, macrophage dysfunction | GSTO1 knockout macrophages or overexpression cell lines |
| Gbb | Synaptic dysfunction, neurodevelopmental disorders | Drosophila Gbb glutathionylation-site mutants |
| NF-kappaB | Non-small cell lung cancer, chronic inflammation | Lung cancer cell lines with NF-kappaB reporters and CRISPR knockout |
Metabolic disorders and diabetes
Dysregulated glutathionylation of UCP2 impairs glucose-stimulated insulin secretion, linking negative regulation of glutathionylation to type 2 diabetes and metabolic syndrome. Dietary selenium manipulation affects PTP1B glutathionylation and triglyceride concentration in the liver, suggesting a role in lipid metabolism and obesity.
Cancer and inflammation
NF-kappaB expression in non-small cell lung cancer is influenced by redox regulation, and glutathionylation can modulate NF-kappaB activity. Glutathione transferase omega 1, which catalyzes glutathionylation, is a key posttranslational regulator in macrophages and may affect tumor-associated inflammation.
Neurodegeneration and synaptic dysfunction
Glutathionylation of the Gbb ligand promotes its proteasome-mediated degradation, inhibiting synapse growth. Negative regulation of this modification is therefore critical for proper synaptic development, and its dysregulation may contribute to neurodegenerative conditions.
From negative regulation of protein glutathionylation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a deglutathionylation enzyme increase protein glutathionylation? | CRISPR knockout of glutaredoxin in cell lines |
| Does a specific cysteine mutation prevent glutathionylation and alter protein function? | Point mutation (Cys-to-Ser) knock-in via CRISPR |
| Does tagging a protein with a glutathionylation sensor reveal dynamic regulation? | Tagged knock-in of redox-sensitive GFP or proximity labeling |
| Does overexpression of a negative regulator reduce glutathionylation and rescue phenotype? | Overexpression cell models |
| Which genes regulate glutathionylation in a genome-wide manner? | CRISPR library screening with glutathionylation reporters |
| Does a disease-associated SNP affect glutathionylation regulation? | Knock-in of the SNP and functional assays |
How to Study the negative regulation of protein glutathionylation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Anti-glutathione immunoblot | Levels of glutathionylated proteins | Assessing changes after knockout or treatment |
| Biotinylated glutathione (BioGEE) labeling | Incorporation of glutathione into proteins | Detecting dynamic glutathionylation |
| Mass spectrometry-based redox proteomics | Identification of specific glutathionylated cysteine sites | Mapping sites regulated by deglutathionylases |
| Insulin secretion assay | Functional impact of UCP2 glutathionylation | Beta-cell studies |
| Phosphatase activity assay | PTP1B activity after glutathionylation | Liver metabolism studies |
| Synapse growth assay | Gbb-mediated synaptic development | Neurodevelopmental research |
| CRISPR library screening | Genes that regulate glutathionylation | Discovery of novel negative regulators |
| Redox-sensitive GFP reporters | Real-time glutathionylation dynamics | Live-cell imaging |
Detection of protein glutathionylation
Protein glutathionylation can be detected by immunoblotting with anti-glutathione antibodies, by biotinylated glutathione analogs, or by mass spectrometry. These methods allow researchers to quantify the extent of glutathionylation on specific proteins and to assess the impact of negative regulators.
Redox proteomics
Redox proteomics approaches, such as differential alkylation coupled with mass spectrometry, enable global identification of glutathionylated cysteine residues. This is useful for mapping sites affected by knockout or overexpression of regulatory enzymes.
Functional assays for metabolic and signaling outcomes
Glutathionylation affects enzyme activity, so functional assays such as insulin secretion measurements, phosphatase activity assays, or synapse growth assays are used to link negative regulation to physiological outcomes.
Genetic screens and reporter systems
CRISPR library screening with glutathionylation-sensitive reporters can identify novel negative regulators. Reporter systems using redox-sensitive fluorescent proteins targeted to specific proteins allow real-time monitoring of glutathionylation dynamics.
How CRISPR Can Be Used to Study GO:0010734 negative regulation of protein glutathionylation
Knockout
CRISPR knockout of genes encoding deglutathionylation enzymes, such as glutaredoxins, can be used to determine whether loss of negative regulation increases protein glutathionylation and alters cellular phenotypes. Knockout of GSTO1 in macrophages can reveal its role in glutathionylation and inflammation.
Point Mutation
Point mutations that substitute a target cysteine with serine prevent glutathionylation at that site, allowing researchers to test the specific contribution of glutathionylation to protein function. For example, mutating the glutathionylation site in Gbb can stabilize the protein and affect synapse growth.
Knock-in
Knock-in of tagged versions of proteins or of redox-sensitive reporters enables real-time monitoring of glutathionylation and its negative regulation in live cells. Knock-in of disease-associated SNPs can also reveal how genetic variation affects glutathionylation control.
Overexpression
Overexpression of negative regulators, such as glutaredoxins or sulfiredoxins, can reduce glutathionylation levels and rescue phenotypes caused by oxidative stress. Conversely, overexpression of glutathionylating enzymes can increase modification and help identify downstream effects.
How EDITGENE Supports negative regulation of protein glutathionylation Research
Researchers studying negative regulation of protein glutathionylation-related genes often need to determine whether a candidate gene is causally involved in controlling this modification, and CRISPR-based models provide the most direct way to establish causality. By combining knockout, point mutation, knock-in, and overexpression strategies, it is possible to dissect the enzymatic and signaling pathways that negatively regulate glutathionylation and to link them to disease phenotypes.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of protein glutathionylation research.
Frequently Asked Questions About negative regulation of protein glutathionylation
What is GO:0010734?
GO:0010734 is the Gene Ontology term for negative regulation of protein glutathionylation, defined as any process that decreases the rate, frequency, or extent of protein glutathionylation.
What is protein glutathionylation?
Protein glutathionylation is a reversible post-translational modification in which a glutathione molecule is added to a protein cysteine via a disulfide linkage.
What genes are involved in negative regulation of protein glutathionylation?
Genes encoding glutaredoxins, sulfiredoxins, glutathione transferases, and proteins like UCP2, PTP1B, GSTO1, and Gbb are involved.
How does negative regulation of glutathionylation affect cell metabolism?
It restores enzyme activity after oxidative stress and prevents sustained metabolic inhibition by desensitizing hydrogen peroxide signals.
What diseases are linked to dysregulated glutathionylation?
Metabolic disorders, type 2 diabetes, cancer, and synaptic dysfunction have been linked to altered glutathionylation control.
What experimental models are used to study negative regulation of glutathionylation?
CRISPR knockout, point mutation, knock-in, overexpression cell models, and redox proteomics are commonly used.
How can I measure protein glutathionylation in my samples?
Anti-glutathione immunoblotting, biotinylated glutathione labeling, and mass spectrometry-based redox proteomics are standard methods.
What is the role of glutaredoxin in deglutathionylation?
Glutaredoxins catalyze the removal of glutathione from protein cysteines, thereby negatively regulating glutathionylation.
Can CRISPR be used to study glutathionylation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise dissection of glutathionylation regulatory pathways.
Why is negative regulation of glutathionylation important for insulin secretion?
The glutathionylation state of UCP2 controls glucose-stimulated insulin secretion, so its negative regulation is critical for beta-cell function.
Conclusion
GO:0010734, negative regulation of protein glutathionylation, is a fundamental biological process that reverses a key oxidative post-translational modification, thereby protecting proteins from irreversible damage and restoring cellular function. Its dysregulation is implicated in metabolic disorders, cancer, and neurodegeneration, making it a compelling area of research. By leveraging CRISPR-based models and redox proteomics, researchers can uncover the precise mechanisms and therapeutic potential of targeting this process.
References
- 1. Mailloux RJ. 2020. Protein S-glutathionylation reactions as a global inhibitor of cell metabolism for the desensitization of hydrogen peroxide signals.. Redox Biol 32:101472 PMID: 32171726
- 2. Mailloux RJ et al.. 2012. Glutathionylation state of uncoupling protein-2 and the control of glucose-stimulated insulin secretion.. J Biol Chem 287(47):39673-85 PMID: 23035124
- 3. Loi VV et al.. 2015. Redox regulation by reversible protein S-thiolation in bacteria.. Front Microbiol 6:187 PMID: 25852656
- 4. Zhang L et al.. 2023. Nuclear factor kappa B expression in non-small cell lung cancer.. Biomed Pharmacother 167:115459 PMID: 37716117
- 6. Mueller AS et al.. 2008. Redox regulation of protein tyrosine phosphatase 1B by manipulation of dietary selenium affects the triglyceride concentration in rat liver.. J Nutr 138(12):2328-36 PMID: 19022953
- 7. Hughes MM et al.. 2017. Glutathione and Glutathione Transferase Omega 1 as Key Posttranslational Regulators in Macrophages.. Microbiol Spectr 5(1) PMID: 28102119
- 8. Hossain MS et al.. 2023. Gbb glutathionylation promotes its proteasome-mediated degradation to inhibit synapse growth.. J Cell Biol 222(9) PMID: 37389657
